BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:16:00 PM | Browse: 1432 | Download: 1341
 |
Received |
|
2014-07-23 20:36 |
 |
Peer-Review Started |
|
2014-07-25 20:34 |
 |
To Make the First Decision |
|
2014-08-14 14:57 |
 |
Return for Revision |
|
2014-08-15 10:00 |
 |
Revised |
|
2014-08-27 07:50 |
 |
Second Decision |
|
2014-10-16 15:07 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-10-16 15:41 |
 |
Articles in Press |
|
2014-10-16 15:41 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-11-20 09:16 |
 |
Publish the Manuscript Online |
|
2014-11-20 19:46 |
Category |
Medicine, Research & Experimental |
Manuscript Type |
Topic Highlights |
Article Title |
Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
|
Manuscript Source |
Invited Manuscript |
All Author List |
Hye-jin Yoon and Bong Soo Cha |
Funding Agency and Grant Number |
|
Corresponding Author |
Bong Soo Cha, MD, PhD, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemoon-gu, Seoul 120-752,
South Korea. bscha@yuhs.ac
|
Key Words |
Non-alcoholic fatty liver disease; Insulin resistance; Drugs; Pathogenesis |
Core Tip |
In this review, we summarize the pathogenesis underlying the progression of hepatic steatosis to steatohepatitis and cirrhosis. We also discuss established drugs that are already being used to treat non-alcoholic fatty liver disease, in addition to newly discovered agents, with respect to their mechanisms of drug action, focusing mainly on hepatic insulin resistance. As well, we review clinical data that demonstrate the efficacy of these drugs, together with improvements in biochemical or histological parameters. Furthermore, we introduced future treatment option for non-alcoholic fatty liver disease.
|
Publish Date |
2014-11-20 19:46 |
Citation |
Yoon HJ, Cha BS. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease. World J Hepatol 2014; 6(11): 800-811 |
URL |
http://www.wjgnet.com/1948-5182/full/v6/i11/800.htm |
DOI |
http://dx.doi.org/10.4254/wjh.v6.i11.800 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345